SCHEMBL5365873

SCHEMBL5365873

CC(C)(C)c1cc(C=O)cc(Br)c1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.46
MAOB P27338 3/20 0.46
THRA P10827 2/20 0.45
THRB P10828 2/20 0.45
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
MAPT P10636 2/20 0.43
ALDH1A1 P00352 2/20 0.43
LMNA P02545 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 1/20 0.43
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
APP P05067 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
RAB9A P51151 1/20 0.40
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
FEN1 P39748 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5366582 0.90 MAOA (0.51) MAOAMAOBMAPTALDH1A1LMNA
SCHEMBL3955227 0.86 THRA (0.57) MAOAMAOBTHRATHRBMAPT
SCHEMBL5368735 0.84 MAOA (0.46) MAOAMAOBMAPTALDH1A1LMNA
SCHEMBL5369726 0.84 MAOA (0.46) MAOAMAOBMAPTALDH1A1LMNA
SCHEMBL20139466 0.82 MAOA (0.49) MAOAMAOBTHRATHRBMAPT
SCHEMBL1542211 0.82 THRB (0.43) MAOAMAOBTHRATHRBEGFR
SCHEMBL5083962 0.81 THRB (0.46) MAOBTHRATHRBMAPTALDH1A1
SCHEMBL6473455 0.81 THRB (0.46) MAOBTHRATHRBMAPTALDH1A1
SCHEMBL5367770 0.80 MAOA (0.42) MAOAMAOBMAPTALDH1A1KMT2A
SCHEMBL3961650 0.80 APP (0.59) THRBMAPTALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
US-6133305-A PREVENTION AND TREATMENT OF PROTEIN KINASE RELATED DISORDERS SUCH AS CANCER SUGEN, INC. (US) 2000-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MAOA 1231/4885MAOB 867/4885THRA 1746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.